

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.70726467 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.70726467 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.98501864 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.72636267 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.07839028 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02504356 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.82706580 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.61935076 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.61935076 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.61935076 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.61935076 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.61935076 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.61935076 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.58359867 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.54834523 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.45397825 |
| 17 | negative thymic T cell selection (GO:0045060) | 4.42409439 |
| 18 | positive thymic T cell selection (GO:0045059) | 4.39538577 |
| 19 | leukocyte aggregation (GO:0070486) | 4.38338653 |
| 20 | activated T cell proliferation (GO:0050798) | 4.36267730 |
| 21 | negative T cell selection (GO:0043383) | 4.35240321 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.30087190 |
| 23 | detection of other organism (GO:0098543) | 4.17886000 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.16554204 |
| 25 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.14868666 |
| 26 | response to interleukin-15 (GO:0070672) | 4.13240372 |
| 27 | positive T cell selection (GO:0043368) | 4.09065834 |
| 28 | detection of bacterium (GO:0016045) | 4.04457178 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 4.02511315 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.92696185 |
| 31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.85861073 |
| 32 | cellular extravasation (GO:0045123) | 3.84266589 |
| 33 | tolerance induction (GO:0002507) | 3.83681808 |
| 34 | T cell selection (GO:0045058) | 3.82245742 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.78191339 |
| 36 | thymic T cell selection (GO:0045061) | 3.75124776 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.64461105 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.60218755 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.50985031 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.43832379 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 3.40314775 |
| 42 | microglial cell activation (GO:0001774) | 3.35561832 |
| 43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31834120 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.29751586 |
| 45 | T cell migration (GO:0072678) | 3.27331193 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24490043 |
| 47 | regulation of tolerance induction (GO:0002643) | 3.23944351 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21634983 |
| 49 | response to peptidoglycan (GO:0032494) | 3.21511385 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.18206655 |
| 51 | regulation of B cell differentiation (GO:0045577) | 3.17575116 |
| 52 | negative regulation of type 2 immune response (GO:0002829) | 3.09658865 |
| 53 | regulation of ARF protein signal transduction (GO:0032012) | 3.07844376 |
| 54 | response to host immune response (GO:0052572) | 3.06050367 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06050367 |
| 56 | positive regulation of Rap GTPase activity (GO:0032854) | 3.04427474 |
| 57 | neutrophil activation (GO:0042119) | 3.04286666 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.04235672 |
| 59 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.03917456 |
| 60 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.03047533 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.02855035 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.01270458 |
| 63 | interferon-gamma production (GO:0032609) | 2.99952424 |
| 64 | positive regulation of tolerance induction (GO:0002645) | 2.98794982 |
| 65 | macrophage activation (GO:0042116) | 2.98170051 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 2.97896307 |
| 67 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96991834 |
| 68 | respiratory burst (GO:0045730) | 2.92200115 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91624799 |
| 70 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91408486 |
| 71 | response to host (GO:0075136) | 2.91408486 |
| 72 | response to host defenses (GO:0052200) | 2.91408486 |
| 73 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.89155794 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.89155794 |
| 75 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.88222932 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.86208153 |
| 77 | neutrophil mediated immunity (GO:0002446) | 2.85737046 |
| 78 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.85734590 |
| 79 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.85734590 |
| 80 | positive regulation of granulocyte differentiation (GO:0030854) | 2.85386818 |
| 81 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85179992 |
| 82 | * response to muramyl dipeptide (GO:0032495) | 2.79749911 |
| 83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78811400 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 2.77533873 |
| 85 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.77064127 |
| 86 | negative regulation of innate immune response (GO:0045824) | 2.76813384 |
| 87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76509703 |
| 88 | negative regulation of adaptive immune response (GO:0002820) | 2.76153307 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 2.75002503 |
| 90 | signal complex assembly (GO:0007172) | 2.74722828 |
| 91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.74276064 |
| 92 | T cell homeostasis (GO:0043029) | 2.74218820 |
| 93 | germinal center formation (GO:0002467) | 2.73469645 |
| 94 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.73411060 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.71488070 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70733507 |
| 97 | leukocyte degranulation (GO:0043299) | 2.70694678 |
| 98 | granulocyte activation (GO:0036230) | 2.70490121 |
| 99 | defense response to protozoan (GO:0042832) | 2.68900830 |
| 100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.67716309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.37188406 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.03202968 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.65227525 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.00237373 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.88281572 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.86799515 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.60788618 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.53811730 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45795285 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44420389 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.41852053 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34013871 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.25353541 |
| 14 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24778237 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.23520802 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.22470106 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.21752382 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.19318980 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.14202929 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13578884 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09001418 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.07239310 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06554206 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03539760 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.00115516 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99383501 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96640658 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95312464 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93237427 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91410344 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88719240 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87768447 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84976597 |
| 34 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.80955853 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.77937524 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76934256 |
| 37 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.72655129 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.69963479 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68817293 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67739772 |
| 41 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.65855277 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60868301 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60715872 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60059594 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56666923 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54660387 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53926634 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.51482994 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48374831 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44373161 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42989355 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42813535 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41582227 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40509191 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38336619 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35287661 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29775693 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23363840 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21854623 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21114755 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19287937 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18763473 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17702951 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14351253 |
| 65 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10332038 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09502661 |
| 67 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05837990 |
| 68 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04635730 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04269590 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03840049 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03351750 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01980154 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01543742 |
| 74 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01281451 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01029706 |
| 76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00768590 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99354862 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97172749 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96494511 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95291305 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95094019 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94531724 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94520187 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93366201 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92218689 |
| 86 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89570189 |
| 87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.89206128 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88736375 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88547865 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88530393 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87466840 |
| 92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86932337 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86911838 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86489802 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 0.85969922 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85927048 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85299084 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83259733 |
| 99 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.83199084 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82769933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.27417544 |
| 2 | MP0003436_decreased_susceptibility_to | 4.02369204 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.24060324 |
| 4 | MP0003303_peritoneal_inflammation | 3.22368502 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.11348319 |
| 6 | MP0001800_abnormal_humoral_immune | 2.97108971 |
| 7 | MP0005671_abnormal_response_to | 2.86594487 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.67965992 |
| 9 | MP0002419_abnormal_innate_immunity | 2.64825436 |
| 10 | MP0001790_abnormal_immune_system | 2.61868262 |
| 11 | MP0005387_immune_system_phenotype | 2.61868262 |
| 12 | MP0000685_abnormal_immune_system | 2.56140612 |
| 13 | MP0005025_abnormal_response_to | 2.48897574 |
| 14 | MP0002723_abnormal_immune_serum | 2.48592092 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.47395092 |
| 16 | MP0001819_abnormal_immune_cell | 2.43619976 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.34515068 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.31146901 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.21333152 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.06799515 |
| 21 | MP0006082_CNS_inflammation | 2.06041521 |
| 22 | MP0009785_altered_susceptibility_to | 1.94734860 |
| 23 | MP0002398_abnormal_bone_marrow | 1.93675161 |
| 24 | MP0002405_respiratory_system_inflammati | 1.88497497 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.87455100 |
| 26 | MP0000716_abnormal_immune_system | 1.86970114 |
| 27 | MP0008260_abnormal_autophagy | 1.81543363 |
| 28 | MP0003690_abnormal_glial_cell | 1.77882103 |
| 29 | MP0003866_abnormal_defecation | 1.76427083 |
| 30 | MP0009278_abnormal_bone_marrow | 1.76232241 |
| 31 | MP0004947_skin_inflammation | 1.71532609 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.70390920 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.68696450 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.67017247 |
| 35 | MP0003828_pulmonary_edema | 1.63257285 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.56087636 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.53122447 |
| 38 | MP0004381_abnormal_hair_follicle | 1.52959141 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.50532193 |
| 40 | MP0002722_abnormal_immune_system | 1.49945510 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.46625717 |
| 42 | MP0003787_abnormal_imprinting | 1.45332454 |
| 43 | MP0001851_eye_inflammation | 1.44344941 |
| 44 | MP0004130_abnormal_muscle_cell | 1.44193319 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.38178466 |
| 46 | MP0002429_abnormal_blood_cell | 1.37107988 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.34140432 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.33425263 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.33109880 |
| 50 | MP0004883_abnormal_blood_vessel | 1.32345890 |
| 51 | MP0003329_amyloid_beta_deposits | 1.28807476 |
| 52 | MP0002132_abnormal_respiratory_system | 1.27541344 |
| 53 | MP0005310_abnormal_salivary_gland | 1.21412397 |
| 54 | MP0003635_abnormal_synaptic_transmissio | 1.21087427 |
| 55 | MP0004510_myositis | 1.19829148 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.15160623 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.13231849 |
| 58 | MP0002933_joint_inflammation | 1.10409439 |
| 59 | MP0000604_amyloidosis | 1.08960721 |
| 60 | MP0008569_lethality_at_weaning | 1.06567415 |
| 61 | MP0009764_decreased_sensitivity_to | 1.03387543 |
| 62 | MP0001873_stomach_inflammation | 1.00837560 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 0.99795883 |
| 64 | MP0001545_abnormal_hematopoietic_system | 0.99795883 |
| 65 | MP0008469_abnormal_protein_level | 0.97253025 |
| 66 | MP0002063_abnormal_learning/memory/cond | 0.96593969 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.96423353 |
| 68 | MP0001958_emphysema | 0.93821080 |
| 69 | MP0005423_abnormal_somatic_nervous | 0.93762520 |
| 70 | MP0003075_altered_response_to | 0.93374713 |
| 71 | MP0000858_altered_metastatic_potential | 0.92185163 |
| 72 | MP0002009_preneoplasia | 0.90632967 |
| 73 | MP0003045_fibrosis | 0.89084053 |
| 74 | MP0002064_seizures | 0.87854814 |
| 75 | MP0001663_abnormal_digestive_system | 0.87486959 |
| 76 | MP0005166_decreased_susceptibility_to | 0.86955954 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.86787477 |
| 78 | MP0008874_decreased_physiological_sensi | 0.85763542 |
| 79 | MP0002928_abnormal_bile_duct | 0.84139389 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.83782010 |
| 81 | MP0000920_abnormal_myelination | 0.83452010 |
| 82 | MP0002133_abnormal_respiratory_system | 0.77634418 |
| 83 | MP0005388_respiratory_system_phenotype | 0.77634418 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.77567807 |
| 85 | MP0005390_skeleton_phenotype | 0.77285333 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.76620344 |
| 87 | MP0005164_abnormal_response_to | 0.75801367 |
| 88 | MP0003091_abnormal_cell_migration | 0.75587238 |
| 89 | MP0001853_heart_inflammation | 0.75177876 |
| 90 | MP0003880_abnormal_central_pattern | 0.75069237 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.74260988 |
| 92 | MP0009745_abnormal_behavioral_response | 0.71171103 |
| 93 | MP0003879_abnormal_hair_cell | 0.70459442 |
| 94 | MP0005535_abnormal_body_temperature | 0.68544987 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.63886835 |
| 96 | MP0001486_abnormal_startle_reflex | 0.62864430 |
| 97 | MP0000249_abnormal_blood_vessel | 0.61833865 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.61490148 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 0.61410789 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.60058129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.06860047 |
| 2 | Myositis (HP:0100614) | 5.10009291 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.98039936 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.71583771 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58668770 |
| 6 | Orchitis (HP:0100796) | 4.50986300 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.45701443 |
| 8 | Optic neuritis (HP:0100653) | 4.45701443 |
| 9 | Stomatitis (HP:0010280) | 4.38284175 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.12970429 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.01677840 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.98697703 |
| 13 | Papilledema (HP:0001085) | 3.92900887 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.85597600 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66124866 |
| 16 | Meningitis (HP:0001287) | 3.58680286 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.48578158 |
| 18 | Increased IgE level (HP:0003212) | 3.47848187 |
| 19 | Recurrent skin infections (HP:0001581) | 3.42579523 |
| 20 | T lymphocytopenia (HP:0005403) | 3.41275529 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.41266658 |
| 22 | Obstructive lung disease (HP:0006536) | 3.41266658 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40668372 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40668372 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.38040555 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.37201728 |
| 27 | Pustule (HP:0200039) | 3.32237658 |
| 28 | Encephalitis (HP:0002383) | 3.28606519 |
| 29 | Vasculitis (HP:0002633) | 3.25033182 |
| 30 | Abnormality of T cell number (HP:0011839) | 3.22362325 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.16393589 |
| 32 | Prolonged bleeding time (HP:0003010) | 3.15082175 |
| 33 | Obstructive sleep apnea (HP:0002870) | 3.00937637 |
| 34 | Keratoconjunctivitis (HP:0001096) | 2.92355866 |
| 35 | Gingivitis (HP:0000230) | 2.90555856 |
| 36 | Cellulitis (HP:0100658) | 2.90057310 |
| 37 | Chest pain (HP:0100749) | 2.85448696 |
| 38 | Hemiplegia (HP:0002301) | 2.82509755 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.76909501 |
| 40 | Leukocytosis (HP:0001974) | 2.74848788 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.73715319 |
| 42 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.73632501 |
| 43 | Hemoptysis (HP:0002105) | 2.73500271 |
| 44 | Diplopia (HP:0000651) | 2.71128450 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.71128450 |
| 46 | Episodic fever (HP:0001954) | 2.67060492 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.66524283 |
| 48 | Abnormality of T cells (HP:0002843) | 2.64947144 |
| 49 | Hypochromic anemia (HP:0001931) | 2.64709961 |
| 50 | Recurrent viral infections (HP:0004429) | 2.59580452 |
| 51 | Urticaria (HP:0001025) | 2.57263147 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.54677025 |
| 53 | Peritonitis (HP:0002586) | 2.52751904 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.41246923 |
| 55 | Granulocytopenia (HP:0001913) | 2.40584575 |
| 56 | Slow saccadic eye movements (HP:0000514) | 2.40545846 |
| 57 | Epistaxis (HP:0000421) | 2.39945876 |
| 58 | Pulmonary embolism (HP:0002204) | 2.39399404 |
| 59 | Papilloma (HP:0012740) | 2.35825003 |
| 60 | Verrucae (HP:0200043) | 2.35825003 |
| 61 | Supranuclear gaze palsy (HP:0000605) | 2.35059577 |
| 62 | Colitis (HP:0002583) | 2.34275488 |
| 63 | Lymphopenia (HP:0001888) | 2.33815186 |
| 64 | Gingival bleeding (HP:0000225) | 2.28173877 |
| 65 | Abnormality of the fingertips (HP:0001211) | 2.26765738 |
| 66 | Arterial thrombosis (HP:0004420) | 2.23022484 |
| 67 | Amyloidosis (HP:0011034) | 2.15236385 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12883753 |
| 69 | Sepsis (HP:0100806) | 2.12296702 |
| 70 | Recurrent bronchitis (HP:0002837) | 2.07779799 |
| 71 | Increased IgM level (HP:0003496) | 2.07412440 |
| 72 | Eosinophilia (HP:0001880) | 2.02866416 |
| 73 | Osteomyelitis (HP:0002754) | 2.00588413 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.00042288 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 1.98392619 |
| 76 | Abnormality of eosinophils (HP:0001879) | 1.93896250 |
| 77 | Anorexia (HP:0002039) | 1.93003060 |
| 78 | Abnormality of the endocardium (HP:0004306) | 1.90732341 |
| 79 | Abnormality of the pleura (HP:0002103) | 1.90114886 |
| 80 | Microcytic anemia (HP:0001935) | 1.88261580 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 1.87763342 |
| 82 | Acne (HP:0001061) | 1.87295829 |
| 83 | Postural instability (HP:0002172) | 1.85330260 |
| 84 | Vertigo (HP:0002321) | 1.84591173 |
| 85 | Ankle clonus (HP:0011448) | 1.84159910 |
| 86 | Viral hepatitis (HP:0006562) | 1.83666253 |
| 87 | Nasal polyposis (HP:0100582) | 1.81480039 |
| 88 | Abnormality of the peritoneum (HP:0002585) | 1.80827993 |
| 89 | Chronic otitis media (HP:0000389) | 1.76428091 |
| 90 | Stomach cancer (HP:0012126) | 1.75619574 |
| 91 | Severe combined immunodeficiency (HP:0004430) | 1.75615813 |
| 92 | Neuronal loss in central nervous system (HP:0002529) | 1.75081961 |
| 93 | Annular pancreas (HP:0001734) | 1.74728564 |
| 94 | Glomerulopathy (HP:0100820) | 1.74089397 |
| 95 | Gangrene (HP:0100758) | 1.73335613 |
| 96 | Restrictive lung disease (HP:0002091) | 1.73037671 |
| 97 | Keratitis (HP:0000491) | 1.71760181 |
| 98 | Skin ulcer (HP:0200042) | 1.68957131 |
| 99 | Basal cell carcinoma (HP:0002671) | 1.68371055 |
| 100 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66108182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.14774299 |
| 2 | MAP4K1 | 3.48172925 |
| 3 | PRPF4B | 2.89578429 |
| 4 | FES | 2.56173830 |
| 5 | BLK | 2.41540598 |
| 6 | TYK2 | 2.33543713 |
| 7 | TXK | 2.27891221 |
| 8 | TNK2 | 2.18704606 |
| 9 | CSK | 2.06513199 |
| 10 | SIK2 | 1.97260397 |
| 11 | IRAK4 | 1.94173788 |
| 12 | GRK6 | 1.90199797 |
| 13 | ZAP70 | 1.85909979 |
| 14 | MAP2K3 | 1.84418618 |
| 15 | MAP3K13 | 1.72790681 |
| 16 | EPHB1 | 1.72749620 |
| 17 | BTK | 1.70960830 |
| 18 | TAOK3 | 1.68853834 |
| 19 | MARK2 | 1.65587586 |
| 20 | ERN1 | 1.62476733 |
| 21 | CAMKK1 | 1.55737961 |
| 22 | SYK | 1.54294173 |
| 23 | JAK1 | 1.52724413 |
| 24 | HCK | 1.50481002 |
| 25 | JAK3 | 1.44365303 |
| 26 | SIK3 | 1.37841838 |
| 27 | IKBKE | 1.36561391 |
| 28 | ITK | 1.35045893 |
| 29 | MAP3K14 | 1.22906549 |
| 30 | KSR2 | 1.21070587 |
| 31 | JAK2 | 1.18631260 |
| 32 | TRIB3 | 1.17243756 |
| 33 | LCK | 1.15040522 |
| 34 | MAP3K11 | 1.13088571 |
| 35 | MAP3K7 | 1.08856566 |
| 36 | MAPK12 | 1.02836799 |
| 37 | MAP3K1 | 1.02336895 |
| 38 | FGR | 1.02025826 |
| 39 | LYN | 1.01704415 |
| 40 | TAOK1 | 1.01372350 |
| 41 | PRKD2 | 1.00531941 |
| 42 | MAP3K3 | 0.99100451 |
| 43 | TBK1 | 0.96498461 |
| 44 | PDK1 | 0.95389801 |
| 45 | MARK3 | 0.95159456 |
| 46 | UHMK1 | 0.94715442 |
| 47 | NTRK2 | 0.94031847 |
| 48 | CAMKK2 | 0.93723453 |
| 49 | TYRO3 | 0.90059979 |
| 50 | SGK3 | 0.90002108 |
| 51 | CDC42BPA | 0.89996997 |
| 52 | FGFR3 | 0.89113814 |
| 53 | SGK2 | 0.87701046 |
| 54 | MAP3K10 | 0.87569654 |
| 55 | STK38 | 0.86633321 |
| 56 | NTRK3 | 0.86434213 |
| 57 | STK11 | 0.85359410 |
| 58 | DAPK2 | 0.84954313 |
| 59 | TEC | 0.84055764 |
| 60 | HIPK2 | 0.83134430 |
| 61 | BMPR2 | 0.82303680 |
| 62 | DYRK1B | 0.82065333 |
| 63 | MAPK7 | 0.81862030 |
| 64 | CDK19 | 0.80773393 |
| 65 | PRKCH | 0.79229912 |
| 66 | CSF1R | 0.78337695 |
| 67 | YES1 | 0.77951943 |
| 68 | SIK1 | 0.75697163 |
| 69 | FYN | 0.74270396 |
| 70 | FGFR4 | 0.73250023 |
| 71 | PAK6 | 0.72957755 |
| 72 | SGK223 | 0.72761335 |
| 73 | SGK494 | 0.72761335 |
| 74 | KIT | 0.72568438 |
| 75 | PTK6 | 0.72539253 |
| 76 | PDPK1 | 0.69930754 |
| 77 | PRKCQ | 0.66352941 |
| 78 | PTK2B | 0.64896473 |
| 79 | NLK | 0.64624329 |
| 80 | IRAK2 | 0.63342238 |
| 81 | RET | 0.62000222 |
| 82 | IKBKB | 0.60296137 |
| 83 | MAP3K2 | 0.56484340 |
| 84 | RIPK1 | 0.54312253 |
| 85 | IRAK1 | 0.52532998 |
| 86 | CAMK4 | 0.51392400 |
| 87 | MAP3K6 | 0.49899545 |
| 88 | MAP2K4 | 0.48684957 |
| 89 | CAMK1 | 0.48465178 |
| 90 | LRRK2 | 0.48359457 |
| 91 | WNK1 | 0.48174239 |
| 92 | STK10 | 0.47851311 |
| 93 | MAP2K2 | 0.45897150 |
| 94 | KSR1 | 0.45814623 |
| 95 | PDGFRB | 0.45114450 |
| 96 | EPHA3 | 0.43363189 |
| 97 | RPS6KL1 | 0.42767160 |
| 98 | RPS6KC1 | 0.42767160 |
| 99 | SGK1 | 0.42366340 |
| 100 | DYRK1A | 0.41513283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32648900 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15000775 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10757413 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07590396 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00141486 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.92838814 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.79725161 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.78812426 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73843932 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.68951387 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63281260 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61937401 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58968617 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.52391443 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50395698 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45027735 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38041060 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35111571 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.33373613 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32498396 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30760398 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27460845 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24381491 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20174088 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19621341 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18614575 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.18612112 |
| 28 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17366936 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17331634 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.16907838 |
| 31 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.16469918 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16295146 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15046134 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12201765 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11296583 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06989028 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06206671 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05430402 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.04766029 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03915331 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02996497 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02339955 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01534496 |
| 44 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00760625 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00268612 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.99015163 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98152321 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97688053 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97576333 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96220874 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93722738 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93571352 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 0.93519991 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93268087 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92485683 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92411064 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92216926 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89821512 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88123561 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88001488 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85592925 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83881486 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83284144 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.82443226 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82143870 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.82037453 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81956809 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81803329 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81019119 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80601319 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78552961 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77456063 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.77153415 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77131195 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76395340 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75542294 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.74524221 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73595226 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72926642 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71519271 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70981447 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70080792 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69818012 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69491109 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68080358 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.67153672 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.67006756 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.66963978 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65833806 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.65530222 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.63611268 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.63494752 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63477717 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63325789 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59122036 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58798477 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58133597 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57606768 |
| 99 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56162937 |
| 100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55482985 |

